Spinal cord stimulation for heart failure: Preclinical studies to determine optimal stimulation parameters for clinical efficacy

John C. Lopshire, Douglas P. Zipes

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Spinal cord stimulation with implantable devices has been used worldwide for decades to treat regional pain conditions and cardiac angina refractory to conventional therapies. Preclinical studies with spinal cord stimulation in experimental animal models of heart disease have described interesting effects on cardiac and autonomic nervous system physiology. In canine and porcine animals with failing hearts, spinal cord stimulation reverses left ventricular dilation and improves cardiac function, while suppressing the prevalence of cardiac arrhythmias. In this paper, we present further canine studies that determined the optimal site and intensity of spinal cord stimulation that produced the most robust and beneficial clinical response in heart failure animals. We then explore and discuss the clinically relevant aspects and potential impediments that may be encountered in translating spinal cord stimulation to human patients with advanced cardiac disease.

Original languageEnglish
Pages (from-to)321-329
Number of pages9
JournalJournal of Cardiovascular Translational Research
Volume7
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Spinal Cord Stimulation
Heart Failure
Canidae
Heart Diseases
Nervous System Physiological Phenomena
Autonomic Nervous System
Cardiac Arrhythmias
Dilatation
Swine
Animal Models
Pain
Equipment and Supplies

Keywords

  • Animal models
  • Autonomic nervous system
  • Heart failure
  • Spinal cord stimulation
  • Ventricular arrhythmias

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics
  • Genetics(clinical)
  • Molecular Medicine
  • Pharmaceutical Science
  • Medicine(all)

Cite this

Spinal cord stimulation for heart failure : Preclinical studies to determine optimal stimulation parameters for clinical efficacy. / Lopshire, John C.; Zipes, Douglas P.

In: Journal of Cardiovascular Translational Research, Vol. 7, No. 3, 2014, p. 321-329.

Research output: Contribution to journalArticle

@article{68e34be178284567bc6ac68d58244492,
title = "Spinal cord stimulation for heart failure: Preclinical studies to determine optimal stimulation parameters for clinical efficacy",
abstract = "Spinal cord stimulation with implantable devices has been used worldwide for decades to treat regional pain conditions and cardiac angina refractory to conventional therapies. Preclinical studies with spinal cord stimulation in experimental animal models of heart disease have described interesting effects on cardiac and autonomic nervous system physiology. In canine and porcine animals with failing hearts, spinal cord stimulation reverses left ventricular dilation and improves cardiac function, while suppressing the prevalence of cardiac arrhythmias. In this paper, we present further canine studies that determined the optimal site and intensity of spinal cord stimulation that produced the most robust and beneficial clinical response in heart failure animals. We then explore and discuss the clinically relevant aspects and potential impediments that may be encountered in translating spinal cord stimulation to human patients with advanced cardiac disease.",
keywords = "Animal models, Autonomic nervous system, Heart failure, Spinal cord stimulation, Ventricular arrhythmias",
author = "Lopshire, {John C.} and Zipes, {Douglas P.}",
year = "2014",
doi = "10.1007/s12265-014-9547-7",
language = "English",
volume = "7",
pages = "321--329",
journal = "Journal of Cardiovascular Translational Research",
issn = "1937-5387",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Spinal cord stimulation for heart failure

T2 - Preclinical studies to determine optimal stimulation parameters for clinical efficacy

AU - Lopshire, John C.

AU - Zipes, Douglas P.

PY - 2014

Y1 - 2014

N2 - Spinal cord stimulation with implantable devices has been used worldwide for decades to treat regional pain conditions and cardiac angina refractory to conventional therapies. Preclinical studies with spinal cord stimulation in experimental animal models of heart disease have described interesting effects on cardiac and autonomic nervous system physiology. In canine and porcine animals with failing hearts, spinal cord stimulation reverses left ventricular dilation and improves cardiac function, while suppressing the prevalence of cardiac arrhythmias. In this paper, we present further canine studies that determined the optimal site and intensity of spinal cord stimulation that produced the most robust and beneficial clinical response in heart failure animals. We then explore and discuss the clinically relevant aspects and potential impediments that may be encountered in translating spinal cord stimulation to human patients with advanced cardiac disease.

AB - Spinal cord stimulation with implantable devices has been used worldwide for decades to treat regional pain conditions and cardiac angina refractory to conventional therapies. Preclinical studies with spinal cord stimulation in experimental animal models of heart disease have described interesting effects on cardiac and autonomic nervous system physiology. In canine and porcine animals with failing hearts, spinal cord stimulation reverses left ventricular dilation and improves cardiac function, while suppressing the prevalence of cardiac arrhythmias. In this paper, we present further canine studies that determined the optimal site and intensity of spinal cord stimulation that produced the most robust and beneficial clinical response in heart failure animals. We then explore and discuss the clinically relevant aspects and potential impediments that may be encountered in translating spinal cord stimulation to human patients with advanced cardiac disease.

KW - Animal models

KW - Autonomic nervous system

KW - Heart failure

KW - Spinal cord stimulation

KW - Ventricular arrhythmias

UR - http://www.scopus.com/inward/record.url?scp=84899420939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899420939&partnerID=8YFLogxK

U2 - 10.1007/s12265-014-9547-7

DO - 10.1007/s12265-014-9547-7

M3 - Article

C2 - 24569871

AN - SCOPUS:84899420939

VL - 7

SP - 321

EP - 329

JO - Journal of Cardiovascular Translational Research

JF - Journal of Cardiovascular Translational Research

SN - 1937-5387

IS - 3

ER -